Japan Genetic Testing Market Insights Forecasts to 2033

• The Market is Growing at a CAGR of 10.11% from 2023 to 2033
• The Japan Genetic Testing Market Size is Expected to Hold a Significant Share by 2033

The Japan Genetic Testing Market is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 10.11% from 2023 to 2033

Market Overview

Genes are the chemical database that contain the instructions for all of the human body's operations. Genetic testing entails looking through this database. DNA alterations, or mutations, that may result in sickness or illness can be found by genetic testing. In order to ascertain whether an individual has altered genetic material, genetic testing entails analyzing the individual's blood or other tissues. Finding out whether a person currently has a hereditary condition or may in the future develop one may be possible using genetic testing. Making life decisions including choosing a career and raising a family can be aided by the knowledge obtained from genetic testing. It can also be used to diagnose a hereditary disease, begin treatment, or implement preventative measures. The DNA found in every one of a person's genes makes up their unique genome. This intricate testing can assist in locating genetic variations that can be connected to health issues.

Report Coverage

This research report categorizes the market for the Japan genetic testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan genetic testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan genetic testing market.

Driving Factors

Genetic testing is essential for screening and occasionally for medical therapy, as it helps determine the probability of developing specific diseases. Additionally, Japan's population is getting older and wants to know how to take better care of their bodies. Their wish is to age gracefully and to stay well into old age. It is one of the main drivers behind Japan's genetic testing market. Furthermore, CMIC, the biggest pharmaceutical contract research organization (CRO) in Japan, is involved in two significant global screening initiatives. Both centers on osteopathy, the primary therapy in which genetic screening can fill gaps in the medical field in Japan and throughout Asia- Pacific region. The market is expanding due in part to increased awareness of genetic insights and customized medicine for well-informed healthcare decisions. Japan's sustained investments in healthcare infrastructure and research suggest that the genetic testing market will experience sustained expansion and innovation in the coming years.

Restraining Factors

The complex nature of predictive genetic testing, consumer/wellness genomics, and equipment costs associated with genomic research could all provide obstacles to the expansion of the Japan genetic testing market in the coming years.

Market Segmentation

The Japan genetic testing market share is classified into technology and application.

• The NGS segment is expected to hold the largest market share through the forecast period.   

The Japan genetic testing market is segmented by technology into NGS and PCR-based testing. Among these, the NGS segment is expected to hold the largest market share through the forecast period. The rise in next-generation sequencing applications, healthcare spending, technology breakthroughs, and genomic mapping programs are all credited with contributing to the expansion.

• The health and wellness-predisposition/risk/tendency segment is expected to dominate the Japan genetic testing market during the forecast period.       

Based on the application, the Japan genetic testing market is divided into traits screening, new baby screening, ancestry & ethnicity, genetic disease carrier status, and health and wellness-predisposition/risk/tendency. Among these, the health and wellness-predisposition/risk/tendency segment is expected to dominate the Japan genetic testing market during the forecast period. The rising acceptance of healthier lifestyles and healthcare sector awareness campaigns have led to a large demand for consumer/wellness genetics testing and predictive genetics.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan genetic testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Genesis Healthcare
• GeneLife
• Takara Bio Inc.
• Sysmex Corporation
• Fujirebio Inc.
• RIKEN GENESIS Co., Ltd.
• M3, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2023, Nabsys 2.0 LLC (Nabsys) and Hitachi High-Tech Corporation (Hitachi High-Tech) jointly announced that Hitachi High-Tech has taken a controlling stake in Nabsys, a company that develops and produces tools and supplies for the investigation of genomic structural variation. Nabsys will become a combined subsidiary of Hitachi High-Tech Group as a result of this deal.

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Genetic Testing Market based on the below-mentioned segments:

Japan Genetic Testing Market, By Technology

• NGS
• PCR-based Testing

Japan Genetic Testing Market, By Application

• Traits Screening
• New Baby Screening
• Ancestry & Ethnicity
• Genetic Disease Carrier Status
• Health and Wellness-Predisposition/Risk/Tendency